logo

Eris Lifesciences Ltd. Financials

15:57 Jun 13

Eris Lifesciences Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
1795.10
+4.00 (+0.22%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Eris Lifesciences Ltd. Financials

Eris Lifesciences Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
1795.10
+4.00 (+0.22%)
15:57 Jun 13
Quality
image/svg+xml

52/100
Medium Financial Strength

Valuation
image/svg+xml

31/100
Mid Valuation

Technical

67/100
Technically Moderately Bullish

Strength

8

Weakness

8

Opportunity

1

Threats

0

12.32 %

ROE %

5.00 %

ROA %

25.86

EPS

209.57

BVPS

12.15 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
1211.86 1347.04 1685.15 2009.14 2893.64
Operating Expenses +
781.29 862.09 1148.4 1334.32 1876.44
Raw Material
276.44 259.29 348.53 379.33 749.46
Increase Decrease in Cost
-38.17 -0.78 3.82 0.72 -35.47
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
229.3 252.25 346.16 403.82 505.09
Miscellaneous Expenses
667.74 634.77 862.55 953.49 1603.6
Operating Profit
430.57 484.95 536.75 674.82 1017.2
Other Income
8.71 26.09 11.15 23.82 18.36
Depreciation
42.98 64.7 117.09 182.6 315.46
Interest
1.8 4.15 26.17 84.8 231.29
Profit before tax and exceptio..
394.5 442.2 404.64 431.24 488.81
Exceptional Items
0 0 0 0 0
PBT
394.5 442.2 404.64 431.24 488.81
Provision for Taxation
39.36 36.41 30.48 34.18 114.2
Net Profit
355.14 405.79 374.16 397.05 374.61
NET Profit after MI
355.14 406.11 382.16 391.98 351.84
EPS
26.14 29.89 28.1 28.82 25.81
Operating Profit Margin (%)
35.53 36 31.85 33.59 35.15
Net Profit Margin (%)
29.31 30.15 22.68 19.51 12.16

Eris Lifesciences Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 54.80 54.90 54.90 54.90 54.90
FII 8.40 8.40 8.00 14.60 14.30
MF 16.60 16.50 17.00 14.50 14.90
Others 1.50 1.50 1.60 1.70 0.70
Shareholder Shares Holding %
Research 360 logo
Download Our App On: